Literature DB >> 22329717

Designed cyclic permutants of HIV-1 gp120: implications for envelope trimer structure and immunogen design.

Piyali Saha1, Sanchari Bhattacharyya, Sannula Kesavardhana, Edward Roshan Miranda, P Shaik Syed Ali, Deepak Sharma, Raghavan Varadarajan.   

Abstract

Most HIV-1 broadly neutralizing antibodies are directed against the gp120 subunit of the env surface protein. Native env consists of a trimer of gp120-gp41 heterodimers, and in contrast to monomeric gp120, preferentially binds CD4 binding site (CD4bs)-directed neutralizing antibodies over non-neutralizing ones. Some cryo-electron tomography studies have suggested that the V1V2 loop regions of gp120 are located close to the trimer interface. We have therefore designed cyclically permuted variants of gp120 with and without the h-CMP and SUMO2a trimerization domains inserted into the V1V2 loop. h-CMP-V1cyc is one such variant in which residues 153 and 142 are the N- and C-terminal residues, respectively, of cyclically permuted gp120 and h-CMP is fused to the N-terminus. This molecule forms a trimer under native conditions and binds CD4 and the neutralizing CD4bs antibodies b12 with significantly higher affinity than wild-type gp120. It binds non-neutralizing CD4bs antibody F105 with lower affinity than gp120. A similar derivative, h-CMP-V1cyc1, bound the V1V2 loop-directed broadly neutralizing antibodies PG9 and PG16 with ∼20-fold higher affinity than wild-type JRCSF gp120. These cyclic permutants of gp120 are properly folded and are potential immunogens. The data also support env models in which the V1V2 loops are proximal to the trimer interface.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329717     DOI: 10.1021/bi300003v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Design of an Escherichia coli expressed HIV-1 gp120 fragment immunogen that binds to b12 and induces broad and potent neutralizing antibodies.

Authors:  Sanchari Bhattacharyya; Pranveer Singh; Ujjwal Rathore; Mansi Purwar; Denise Wagner; Heather Arendt; Joanne DeStefano; Celia C LaBranche; David C Montefiori; Sanjay Phogat; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

2.  A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.

Authors:  Rohini Datta; Rohan Roy Chowdhury; Kavyashree Manjunath; Luke Elizabeth Hanna; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

3.  Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.

Authors:  Ujjwal Rathore; Mansi Purwar; Venkada Subramanian Vignesh; Raksha Das; Aditya Arun Kumar; Sanchari Bhattacharyya; Heather Arendt; Joanne DeStefano; Aaron Wilson; Christopher Parks; Celia C La Branche; David C Montefiori; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

4.  Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies.

Authors:  Sannula Kesavardhana; Raksha Das; Michael Citron; Rohini Datta; Linda Ecto; Nonavinakere Seetharam Srilatha; Daniel DiStefano; Ryan Swoyer; Joseph G Joyce; Somnath Dutta; Celia C LaBranche; David C Montefiori; Jessica A Flynn; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2016-11-22       Impact factor: 5.157

5.  Tribody: robust self-assembled trimeric targeting ligands with high stability and significantly improved target-binding strength.

Authors:  Dongwook Kim; Sang Kyun Kim; C Alexander Valencia; Rihe Liu
Journal:  Biochemistry       Date:  2013-10-03       Impact factor: 3.162

6.  A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques.

Authors:  Anusmita Sahoo; Andrew T Jones; Narayanaiah Cheedarla; Sailaja Gangadhara; Vicky Roy; Tiffany M Styles; Ayalnesh Shiferaw; Korey L Walter; LaTonya D Williams; Xiaoying Shen; Gabriel Ozorowski; Wen-Hsin Lee; Samantha Burton; Lasanajak Yi; Xuezheng Song; Zhaohui S Qin; Cynthia A Derdeyn; Andrew B Ward; John D Clements; Raghavan Varadarajan; Georgia D Tomaras; Pamela A Kozlowski; Galit Alter; Rama Rao Amara
Journal:  Sci Immunol       Date:  2022-07-22

7.  A single residue within the V5 region of HIV-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody VRC01.

Authors:  Dongxing Guo; Xuanling Shi; Kelly C Arledge; Dingka Song; Liwei Jiang; Lili Fu; Xinqi Gong; Senyan Zhang; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2012-10-25       Impact factor: 5.157

8.  Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains.

Authors:  Narayanaiah Cheedarla; Babu Hemalatha; Brahmaiah Anangi; Kannan Muthuramalingam; Murugesan Selvachithiram; Pattabiraman Sathyamurthi; Nandagopal Kailasam; Raghavan Varadarajan; Soumya Swaminathan; Srikanth Prasad Tripathy; S Kalyanaraman Vaniambadi; D Ramanathan Vadakkupattu; Luke Elizabeth Hanna
Journal:  Front Immunol       Date:  2018-03-27       Impact factor: 7.561

9.  A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.

Authors:  Andrew T Jones; Venkateswarlu Chamcha; Sannula Kesavardhana; Xiaoying Shen; David Beaumont; Raksha Das; Linda S Wyatt; Celia C LaBranche; Sherry Stanfield-Oakley; Guido Ferrari; David C Montefiori; Bernard Moss; Georgia D Tomaras; Raghavan Varadarajan; Rama Rao Amara
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

10.  Genotypic Prediction of Co-receptor Tropism of HIV-1 Subtypes A and C.

Authors:  Mona Riemenschneider; Kieran Y Cashin; Bettina Budeus; Saleta Sierra; Elham Shirvani-Dastgerdi; Saeed Bayanolhagh; Rolf Kaiser; Paul R Gorry; Dominik Heider
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.